Dexcom Inc. (NSDQ:DXCM) last week claimed a win along one front of its patent war with AgaMatrix subsidiary WaveForm Technologies, when an Oregon federal court dismissed a lawsuit alleging that its continuous glucose monitors infringe WaveForm patents.
Wilsonville, Ore.-based WaveForm sued Dexcom in March 2016, alleging infringement of a trio of patents covering a compound material analyte sensor and an indwelling analyte sensor by Dexcom’s G4 and G5 CGMs, according to documents filed in the U.S. District Court for Oregon. In January the companies agreed to drop the indwelling sensor patent from the suit, after the U.S. Patent Trial & Appeal Board found the claims at issue in the lawsuit to be unpatentable.
Get the full story at our sister site, Drug Delivery Business News
